Clune & Associates LTD. Acquires Shares of 99,324 Integral Ad Science Holding Corp. (NASDAQ:IAS)

Clune & Associates LTD. bought a new stake in Integral Ad Science Holding Corp. (NASDAQ:IAS) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 99,324 shares of the company’s stock, valued at approximately $1,037,000. Clune & Associates LTD. owned 0.06% of Integral Ad Science as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of Integral Ad Science by 47.6% during the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock worth $7,756,000 after buying an additional 231,271 shares during the period. Invenomic Capital Management LP lifted its position in shares of Integral Ad Science by 57.4% in the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock valued at $6,327,000 after buying an additional 213,488 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Integral Ad Science by 2.3% in the fourth quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company’s stock valued at $94,467,000 after buying an additional 205,562 shares during the last quarter. Monimus Capital Management LP acquired a new stake in shares of Integral Ad Science in the fourth quarter valued at approximately $2,020,000. Finally, one8zero8 LLC bought a new position in shares of Integral Ad Science during the fourth quarter worth approximately $1,702,000. 95.78% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Oppenheimer restated an “outperform” rating on shares of Integral Ad Science in a research note on Friday, February 28th. Scotiabank assumed coverage on Integral Ad Science in a research note on Friday, February 28th. They issued a “sector perform” rating and a $12.00 price target on the stock. Truist Financial raised their price objective on Integral Ad Science from $16.00 to $17.00 and gave the company a “buy” rating in a report on Monday, March 3rd. Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Morgan Stanley reaffirmed a “mixed” rating on shares of Integral Ad Science in a report on Monday, March 3rd. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Integral Ad Science presently has a consensus rating of “Moderate Buy” and a consensus price target of $15.06.

Integral Ad Science Trading Down 1.0 %

Shares of IAS stock opened at $8.90 on Monday. The company has a market cap of $1.46 billion, a P/E ratio of 44.50, a PEG ratio of 1.06 and a beta of 1.45. Integral Ad Science Holding Corp. has a fifty-two week low of $7.98 and a fifty-two week high of $13.62. The stock has a 50 day simple moving average of $10.12 and a two-hundred day simple moving average of $10.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71.

Integral Ad Science (NASDAQ:IAS) last released its earnings results on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million for the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.06 EPS. Research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Insiders Place Their Bets

In other Integral Ad Science news, CEO Lisa Utzschneider sold 12,448 shares of the firm’s stock in a transaction on Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total value of $132,073.28. Following the transaction, the chief executive officer now directly owns 278,650 shares of the company’s stock, valued at approximately $2,956,476.50. This trade represents a 4.28 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders sold 19,109 shares of company stock worth $197,696. 2.00% of the stock is currently owned by company insiders.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.